Clinical Trial Update: Riboflavin for Glutamate Reduction in Alcohol Withdrawal [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring riboflavin to reduce glutamate in alcohol withdrawal, with ongoing status not yet determined.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol Withdrawal
• Nutrition Disorders

Drugs mentioned

• Riboflavin (riboflavin)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Alcohol Withdrawal, Nutrition Disorders | Phase 2 | Status: UNKNOWN